drugs used in peptic ulcer and dyspepsia Flashcards
Peptic ulcer by Use of Nonsteroidal anti-inflammatory drug (NSAID)
Treatment Approaches?
Avoidance of NSAIDs/ prevention of ulcer
Inadequate mucosal defense against gastric acid
Treatment Approaches?
Protecting the gastric mucosa from damage
3 Drugs Classification
- Agents that reduce intragastric secretion/acidity
- Agents that enhance mucosal resistance/cytoprotective agents
- Drugs for treatment of Helicobacter Pylori infection
Agents that reduce intragastric secretion/acidity
1.Proton pump inhibitors(PPIs):
Omeprazole, esomeprazole, lansoprazole, dexlansoprazole, rabeprazole, pantoprazole
2. H2-receptor antagonists:
Cimetidine, ranitidine, famotidine
3. Antacids:
Aluminum hydroxide, calcium carbonate, Mg(OH)2, NaHCO3
Muscarinic antagonists (pirenzepine, telenzepine, propantheline, etc.)
Agents that enhance mucosal resistance/cytoprotective agents
Prostaglandin analogs:
Misoprostol, Sucralfate
Miscellaneous: carbenoxolone, bismuth compounds
Drugs for treatment of Helicobacter Pylori infection
Antibiotics:
Amoxicillin, Bismuth compounds, Clarithromycin, Metronidazole, Tetracycline
Triple therapy :(PPI + clarithromycin + amoxicillin or metronidazole)
Quadruple therapy: (PPI + metronidazole + Bismuth subnitrate + tetracycline)
Effects of Drugs on Acid Secretion
- H2 receptor antagonist
- Proton pump inhibitor
H2-receptor antagonist has a marked effect upon nocturnal acid secretion
Proton pump inhibitor suppresses meal-stimulated and nocturnal acid secretion
Proton pump inhibitors (PPI)
- examples
- What else does this drug require?
- 2 MOAs
- ROA
- Therapeutic Uses
1.PROLED:Pantoprazole,Rabeprazole,Omeprazole, Lansoprazole,Esomeprazole, Dexlansoprazole,
- Prodrugs - given 30min before meal
- After absorption into systemic circulation, the prodrug diffuses into parietal cells and activated in the acidic secretory canaliculi - MOA:
- Irreversibly binds covalently with H+ K+-ATPase ( require18 hours to resynthesize new enzyme)
- Inhibit both basal and stimulated gastric acid secretion
4. enteric coated capsule / tablet / powder for suspension to protect them from premature degradation by gastric acid; intravenous :pantoprazole / lansoprazole
5.For short-term treatment 4-8 weeks for GU and DU
Zollinger-Ellison Syndrome (pathologic hypersecretion)
Treatment and prevention of NSAID-associated GU, Prevention of stress related mucosal bleeding(critical illness)
Multiple endocrine hyperplasia
PPI PHARMACOKINETICS
- ABSORPTION
- METABOLISM- what enzyme?
- excretion
- how many days therapy? - PROTEIN BINDING
- GIVEN HOW MANY TIMES DAILY?
- WHEN IS DOSE REDUCTION REQUIRED?
1.Rapid absorption from small intestine
2. Extensively metabolised by CYP2C19 (slow metabolizer)
-Metabolites excreted in urine and faeces
-Takes ~5 days of therapy to get 70% inhibition of acid secretion at once daily dose.
3Highly protein bound.
4.Usually given twice daily.
5.Dose reduction needed in liver disease, but not in chronic renal failure.
PPI 8 ADVERSE EFFECTS
- Headache,
- Abdominal pain, diarrhoea, constipation,
- Myopathy
- Arthralgia, rash
- Vitamin B12 /Fe deficiency
- Prolonged hypochlorhydria
- Secondary hypergastrinemia/acid rebound,
- Use of these drugs can “mask” the symptoms of gastric cancer
PPI Drug Interaction
- Omeprazole inhibits the metabolism of warfarin, phenytoin, diazepam, and cyclosporine.
- PPIs + Clopidogrel → ↑ risk of major cardiovascular events OR acute coronary syndrome(↓ CYP2C19/3A4)
- ↑Fracture risk (↓ Ca2+ absorption, impaired activity of osteoclasts)
- Hypomagnesemia
- ↑ Enteric infections
- ↑ Community Acquired Pneumonia
- ↑ Neoplasia (gastric polyps/gastric cancer/gastric carcinoids/colon cancer)
PPI Drug administration- when?
- what should be taken after for
best effect?
- Regimen for GERD symptoms?
- PPIs should be taken 30 minutes before breakfast or the largest meal of the day.
- H2-receptor antagonist (if also needed) should be taken well after the PPI for best effect.
- In patients with GERD, PPI twice-daily regimen or PPI in the morning and adding an H2 antagonist in the evening may improve symptom control.
Agents Reduce Intragastric Secretion :
H2 receptor antagonists
- 5 EXAMPLES
- 2 MOA
- EXAMPLE: Cimetidine, Ranitidine, Famotidine, Nizatidine, Roxatidine
Cimetidinewas the prototypical histamine H2-receptor antagonist from which later drugs were developed. - MOA:
-Inhibit acid production by reversible inhibition of H2-receptors on basolateral membrane of parietal cell.
-Mainly inhibit nocturnal acid secretion
H2 receptor antagonists PHARMACOKINETICS
- ABSORPTION
- HOW MANY TIMES DAILY
- PROTEIN BINDING
- METABOLISM - in liver
- excretion - DOSE REDUCTION
PHARMACOKINETICS:
- Rapid absorption, peak 1-3 hr.
- Can be given twice daily in doses of 400-600 mg or 800mg at bedtime
- Minimal protein binding.
- Metabolized <30% in liver. Excreted in urine (reduce dose in renal impairment).
- dose reduction in renal disease
H2 receptor antagonists SIDE EFFECTS
- In general, well tolerated, except forcimetidine
- Few S/E reported: Diarrhoea, headache, drowsiness, fatigue, muscle pain, confusion, hallucination, slurred speech, blood dyscrasias
- Crosses placenta, and Secreted in breast milk